Heart Failure

All Post
Chronic Limb Threatening Ischemia
Heart Failure
Wound Care

Topics

Chronic Limb Threatening Ischemia
Heart Failure
Wound Care

Subscribe

Heart Failure

New Hope for Heart Health

Exploring ACP-01 and the Future of Heart Failure ❤️

Cardiovascular disease remains a leading...

4 minute read

Croom Lawrence

5 September 2025

VesCell (ACP-01) is an investigational therapy under development and not approved by the FDA. VesCell is available through special access programs that may be approved on a case-by-case basis in Canada, Bahamas and Domican Republic for treatment of no option patients suffering from CLTI, no option patients suffering from chronic stable angina, no option ischemic and non-ischemic dilated cardiomyopathy.

Resources

Story
Science
- Critical Limb Ischemia
- Vascular Dementia
Savings
Events
FAQ
Registry
GLOBAL

Heart Failure

New Hope for Heart Health

Exploring ACP-01 and the Future of Heart Failure ❤️

Resources

We're here to help